| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |